Table 2 Maximal treatment response
|  | IRD (N = 127) | RD (N = 217) | p1 |
|---|---|---|---|
Maximal treatment response, n (%) | n = 126 | n = 216 |  |
sCR | 2 (1.6%) | – | 0.095 |
CR | 12 (9.5%) | 19 (8.8%) | |
VGPR | 28 (22.2%) | 30 (13.9%) | |
PR | 50 (39.7%) | 94 (43.5%) | |
MR | 11 (8.7%) | 34 (15.7%) | |
SD | 13 (10.3%) | 17 (7.9%) | |
PD | 10 (7.9%) | 22 (10.2%) | |
VGPR+ a | 42 (33.3%) | 49 (22.7%) | 0.042 |
ORRb | 92 (73.0%) | 143 (66.2%) | 0.227 |
CBRc | 103 (81.7%) | 177 (81.9%) | 1.000 |